Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Coenzyme Q10

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 235Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BPGbio Gets FDA Orphan Status for BPM31510 in CoQ10 Deficiency
    BPGbio Gets FDA Orphan Status for BPM31510 in CoQ10 Deficiency

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3223199/0/en/UPDATE-BPGbio-Receives-FDA-Orphan-Drug-Designation-for-BPM31510-for-the-Treatment-of-Primary-CoQ10-Deficiency.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    FDA Grants BPGbio Orphan Status for BPM31510 in CoQ10 Deficiency
    FDA Grants BPGbio Orphan Status for BPM31510 in CoQ10 Deficiency

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221557/0/en/BPGbio-Receives-FDA-Orphan-Drug-Designation-for-BPM31510-for-the-Treatment-of-Primary-CoQ10-Deficiency.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    The first potent COQ8 inhibitor targets ubiquinone biosynthesis
    The first potent COQ8 inhibitor targets ubiquinone biosynthesis

    28 Nov 2022

    // HIPPOCRATICPOST

    https://www.hippocraticpost.com/screening/the-first-potent-coq8-inhibitor-targets-ubiquinone-biosynthesis/

    HIPPOCRATICPOST
    28 Nov 2022
    Share Share
    Health Canada Recalls Pharm Canada's Passion Fem Capsules; Natura-One Passion Fem Capsules
    Health Canada Recalls Pharm Canada's Passion Fem Capsules; Natura-One Passion Fem Capsules

    07 Oct 2019

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-recalls-pharm-canadas-passion-fem-capsules-natura-one-passion-fem-capsules-1570514947.pdf

    HEALTH CANADA
    07 Oct 2019
    Share Share
    Enforcement Report - Week of April 25, 2018
    Enforcement Report - Week of April 25, 2018

    25 Apr 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-25-2018-1524633895.pdf

    FDA
    25 Apr 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.